← Evidence map

ArticleOncotarget2016

CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers.

Federica Turdo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

28 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27626701